Form 4 holding
Director
Reneo Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 17,500
- Estimated value
- Report date
- 06 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount